Fig 5. One-way sensitivity analysis of intermediate-dose PQ treatment guided by G6PD testing(100% access), compared to low-dose PQ without G6PD testing.

Values for each variable were set at the minimum (blue) and maximum (red) values in independent simulations to investigate the impact on model predictions for number of severe haemolysis events (top) and P. vivax recurrences within 6 months of treatment (bottom) in male patients with 1% G6PDd prevalence. Only variables impacting each outcome are shown.